KNCV Tuberculosis Foundation (KNCV) is one of the leading international non-profit organizations dedicated to fighting tuberculosis (TB) worldwide. We are an international center of expertise for TB control that stimulates effective, efficient and sustainable tuberculosis control strategies in a national and international context. We are an organization of passionate TB professionals; including medical doctors, researchers, training experts, nurses and epidemiologists.
Over the past century we have built a wealth of knowledge and expertise, initially by successfully driving back TB in the Netherlands, and subsequently by partnering in the fight against TB in over 40 countries worldwide.
We operate from a central office in The Hague in the Netherlands and additional country offices worldwide). KNCV raises funds from individual, institutional and corporate donors.
ASCENT Project Background
Historically, the most widely-implemented means of supporting TB patients and ensuring adherence for their treatment is Directly Observed Treatment (DOT). With DOT, a health care worker observes (in-person) the patient’s daily ingestion of medication, either at the health facility or patient’s home. While the DOT approach has advanced global decline in TB incidence, innovations are needed to address existing gaps, enable system efficiencies, improve patient-centered care, empower providers and patients and achieve greater impact for all types of TB.
By taking advantage of today’s powerful communication mechanisms, the implementation of digital adherence technologies (DAT) can help to overcome health care disparities by allowing patients greater freedom to self-manage and participate in their own care, reduce financial burdens and restore autonomy and dignity, and simultaneously empower providers with accurate and timely information to provide differentiated care.
KNCV Tuberculosis Foundation (KNCV) leads the ASCENT (Adherence Support Coalition to End TB- project), the new Unitaid-funded 3 year project that will implement DAT interventions in five key countries (Ethiopia, the Philippines, South Africa, Tanzania, and Ukraine) in order to enable innovative new patient-centered, optimized TB care pathways for all types of TB (DS-TB, DR-TB, LTBI) and support the growing global momentum towards the use of these technologies.
The M&E Officer is responsible for the monitoring and evaluation of project implementation to improve performance and impact, as well as to document and communicate project achievements and lessons learned. S/he works in close collaboration with the ASCENT project team in-country as well as in the Netherlands.
Place in the organization
The M&E Officer reports to the ASCENT Project Manager in Ethiopia.
As the M&E Officer you will:
Monitoring & Evaluation
Communication
Who are we looking for?
Education
Knowledge/experience
Behavioral competencies and skills
What do we offer?